Correlation Engine 2.0
Clear Search sequence regions


  • alleles (1)
  • carcinogens (1)
  • cholesterol (1)
  • CYP1A (8)
  • CYP1A1 (8)
  • drug targets (1)
  • estradiol (1)
  • function (2)
  • genes (5)
  • genotypes (1)
  • homeostasis (1)
  • humans (1)
  • monooxygenases (1)
  • oxygenases (2)
  • P 450 (4)
  • P450 (1)
  • pathogenesis (1)
  • phenotypes (2)
  • SNPs (2)
  • suggests (1)
  • Sizes of these terms reflect their relevance to your search.

    The humancytochrome P450 1A (CYP1A) subfamily genes, CYP1A1 and CYP1A2, encoding monooxygenases are critically involved in biotransformation of key endogenous substrates (estradiol, arachidonic acid, cholesterol) and exogenous compounds (smoke constituents, carcinogens, caffeine, therapeutic drugs). This suggests their significant involvement in multiple biological pathways with a primary role of maintaining endogenous homeostasis and xenobiotic detoxification. Large interindividual variability exist in CYP1A gene expression and/or catalytic activity of the enzyme, which is primarily due to the existence of polymorphic alleles which encode them. These polymorphisms (mainly single nucleotide polymorphisms, SNPs) have been extensively studied as susceptibility factors in a spectrum of clinical phenotypes. An in-depth understanding of the effects of polymorphic CYP1A genes on the differential metabolic activity and the resulting biological pathways is needed to explain the clinical implications of CYP1A polymorphisms. The present review is intended to provide an integrated understanding of CYP1A metabolic activity with unique substrate specificity and their involvement in physiological and pathophysiological roles. The article further emphasizes on the impact of widely studied CYP1A1 and CYP1A2 SNPs and their complex interaction with non-genetic factors like smoking and caffeine intake on multiple clinical phenotypes. Finally, we attempted to discuss the alterations in metabolism/physiology concerning the polymorphic CYP1A genes, which may underlie the reported clinical associations. This knowledge may provide insights into the disease pathogenesis, risk stratification, response to therapy and potential drug targets for individuals with certain CYP1A genotypes. Copyright © 2023 Elsevier B.V. All rights reserved.

    Citation

    Samiksha Kukal, Sarita Thakran, Neha Kanojia, Saroj Yadav, Manish Kumar Mishra, Debleena Guin, Pooja Singh, Ritushree Kukreti. Genic-intergenic polymorphisms of CYP1A genes and their clinical impact. Gene. 2023 Mar 20;857:147171

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36623673

    View Full Text